Leukemia inhibitory factor (LIF) is considered as one of the effective factors in the growth of breast cancer, and anti-leukemia inhibitory factor antibody is considered as one of the treatment options for this type of cancer.<h4>Methods</h4>Mice models of breast cancer were made with 4T1 cell line and were randomly divided into four groups. The gene discussed is LIF; the disease is breast cancer.